在多样化的患者群体中,高风险CCTA表型的心脏代谢预测因素
Toshiki Kuno1, Javier Arce1, Michael Fattouh1
1Cardiology Division, Montefiore Medical Center, Montefiore Medical Center/Albert Einstein Colalege of Medicine, Cardiology Division. 111 E210th, Bronx, NY 10467, United States.
American journal of preventive cardiology
|September 7, 2023
概括
低衰减非化斑块 (LAP) 负担预测心血管结果,特别是在西班牙裔患者中. 与高血压等风险因素相关的LAP升高是显著的预后标志物.
科学领域:
- 心脏病学 心脏病学
- 放射学 放射学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 冠状动脉CT血管图 (CCTA) 识别高风险斑块特征,如低衰减非化斑块 (LAP) 和冠状动脉脂肪组织 (PCAT) 炎症.
- 这些成像生物标志物与心血管结果有关.
研究的目的:
- 调查心脏代谢风险因素之间的关系,包括脂蛋白和心表脂肪组织 (EAT),以及CCTA衍生的LAP和血管炎症.
- 评估这些成像生物标志物的预后意义.
主要方法:
- 对364名接受CCTA治疗的患者进行了回顾性分析,以治疗稳定的胸痛.
- 半自动软件用于从CT测量斑块,PCAT和EAT.
- 已定义的LAP升高 (≥4%) 和PCAT减弱 (≥70.5 HU).
- 主要终点:心肌梗塞,再血管化或心血管死亡的组合.
主要成果:
- 升高LAP的患病率为31%,升高PCAT减弱率为18%.
- 在西班牙裔患者中,脂蛋白与LAP负担相关.
- 升高的LAP与老年,糖尿病,高血压,高脂血症,吸烟,高CAC和增加EAT体积有关.
- 升高的LAP,但没有升高的PCAT,与不良心血管结果有显著的关联 (P<0.001).
结论:
- 升高的LAP负担是心血管事件的重要预测因素.
- 诸如高血压和高脂血症等心脏代谢风险因素增加了LAP升高的几率.
- 脂蛋白 (a) 与特定族群 (西班牙裔患者) 的LAP负担存在相关性.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
39
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Imaging Studies for Cardiovascular System V: CT
41
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
41
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
118
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
118


